Schaller, Stefan J.
Scheffenbichler, Flora T.
Bose, Somnath
Mazwi, Nicole
Deng, Hao
Krebs, Franziska
Seifert, Christian L.
Kasotakis, George
Grabitz, Stephanie D.
Latronico, Nicola
Houle, Timothy
Blobner, Manfred
Eikermann, Matthias
Funding for this research was provided by:
Jeff and Judy Buzen (222302)
Article History
Received: 23 November 2018
Accepted: 9 January 2019
First Online: 21 January 2019
Compliance with ethical standards
:
: Stefan J. Schaller received research support from MSD (Haar, Germany) not related to this manuscript. He holds stocks from Rhoen-Klinikum, Bayer AG and Siemens AG and held stocks in the recent past from GE Healthcare, Merck and Co., Inc., and Fresenius SE. These holdings have not affected any decisions regarding his research or this study. Flora T. Scheffenbichler reports no disclosures. Nicole Mazwi reports no disclosures. Hao Deng reports no disclosures. Franziska Krebs reports no disclosures. Christian L. Seifert reports no disclosures. George Kasotakis reports no disclosures. Stephanie D Grabitz reports no disclosures. Nicola Latronico reports no disclosures. Somnath Bose reports no disclosures. Timothy Houle reports no disclosures. Manfred Blobner received research support from MSD (Haar, Germany) not related to this manuscript; he received honoraria for lectures from GE Healthcare (Helsinki, Finland) and GrĂ¼nenthal (Aachen, Germany). Matthias Eikermann received research support from Merck not related to this manuscript; he also received research support for this study from Jeff and Judy Buzen.
: For this analysis was obtained by the institutional review board of Massachusetts General Hospital (protocol number 2016P002199) and registered at Clinical Trials (NCT03666338).